Regulatory Medical Writer - One-Year Contract

Novo Nordisk A/S; Søborg; Remote; DKK 570,000 - 838,000; Full time

Benefits offered by this job

Short-term incentives

Long-term incentives

Employee benefits

Job summary

Novo Nordisk A/S in Søborg, Denmark, is seeking an Experienced Medical Writer for a one-year temporary position in Global Regulatory & R&D Quality. You will lead regulatory documents from planning to final versions, coordinating with cross-functional teams to ensure accurate data presentation and timely submissions.

The role requires a Master’s degree in natural sciences, strong English communication, and a proactive, collaborative approach to drive regulatory science writing across trials and

Qualifications

• Master’s degree in natural sciences or equivalent.
• Experience driving complex tasks with multidisciplinary stakeholders.
• Ability to tailor scientific information for different objectives.
• Understanding of clinical development and regulatory documents.
• Excellent English communication.
• Strong planning and coordination under tight deadlines.
• Collaborative, proactive stakeholder management.

Responsibilities

• Lead planning, development and oversight of regulatory documents.
• Represent Regulatory Scientific Writing on cross-functional project teams.
• Ensure source data is reported accurately and interpreted scientifically.
• Keep documents on track against project timelines.
• Share best practices and streamline processes.

Skills

Scientific writing

Project management

Regulatory writing

Stakeholder collaboration

Education

Master’s degree in natural sciences

Job description

Novo Nordisk A/S in Søborg, Denmark, is seeking an Experienced Medical Writer for a one-year temporary position in Global Regulatory & R&D Quality. You will lead regulatory documents from planning to final versions, coordinating with cross-functional teams to ensure accurate data presentation and timely submissions.

The role requires a Master’s degree in natural sciences, strong English communication, and a proactive, collaborative approach to drive regulatory science writing across trials and